The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUBX.L Regulatory News (SUBX)

  • There is currently no data for SUBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Subex Limited-Outcome of Board Meeting

25 May 2016 10:51

RNS Number : 2655Z
Subex Limited
25 May 2016
 

 

 

 

 

 

 

May 25, 2016

To

The London Stock Exchange

10 Paternoster Square

London

EC4M 7LS

Dear Sirs,

Sub: Subex Limited 'The Company'-Outcome of the Board Meeting held on May 24, 2016

Please be informed that the agenda item summarized hereunder was discussed and approved at the Board Meeting held on May 24, 2016

Ø Approval of the audited standalone and consolidated Financial Results of the Company for the year ended March 31, 2016.

 

 Please find hereto enclosed consolidated Financial Results of the Company.

We request you to take the aforesaid notification on record.

Yours faithfully

For and on behalf of Subex Limited

 

Ganesh K V

Chief Financial Officer, Global Head -Legal and Company Secretary

SUBEX LIMITED

 

Registered office: RMZ Ecoworld, Outer Ring Road, Devarabisanahalli, Bangalore - 560 037

 

Statement of Consolidated Audited Results for the quarter and year ended March 31, 2016

 

PART I

( Rs. in Lakhs unless otherwise stated)

Consolidated

3 months ended

Preceding 3 months

Corresponding 3 months

Current year ended

Previous year ended

Particulars

March 31,

ended December 31,

ended March 31,

March 31,

March 31,

2016

2015

2015

2016

2015

Audited (refer note

Unaudited

Audited (refer note 11)

Audited

Audited

11)

1

Income from operations

8,083

11,216

32,335

35,983

Net sales/ income from operations

8,947

Total income from operations (net)

8,947

8,083

11,216

32,335

35,983

2

Expenses

84

1,155

42

1,664

(a)

Cost of hardware, software and support charges (refer note 6)

(138)

(b)

Employee benefits expense and sub- contract charges (refer note 7)

4,677

4,127

3,439

17,625

16,376

(c)

Other expenditure (refer note 8)

1,659

2,115

2,652

7,421

8,685

(d)

Depreciation and amortisation expense

110

110

93

427

402

(e)

Exchange fluctuation (gain)/loss (net)

(630)

(15)

812

827

1,250

Total expenses

5,678

6,421

8,151

26,342

28,377

3

Profit from operations before other income, finance costs and exceptional

3,269

1,662

3,065

5,993

7,606

items (1-2)

4

Other income

63

14

60

121

97

5

Profit from ordinary activities before finance costs and exceptional items

3,332

1,676

3,125

6,114

7,703

(3+4)

6

Finance costs

484

839

2,276

3,352

(a)

Interest on FCCBs (net)

293

(b)

Interest on term loan

254

245

219

974

850

(c)

Other finance costs

383

375

435

1,394

1,902

Total finance costs

930

1,104

1,493

4,644

6,104

7

Profit from ordinary activities before exceptional items and tax (5-6)

2,402

572

1,632

1,470

1,599

8

Exceptional items (net) (refer note 4)

(3,367)

5,620

-

5,675

-

9

(Loss)/ profit from ordinary activities before tax (7+8)

(965)

6,192

1,632

7,145

1,599

10

Tax expense (net)

186

254

187

1,273

578

11

Net (loss)/ profit for the period/year (9-10)

(1,151)

5,938

1,445

5,872

1,021

12

Paid up equity share capital (face value of Rs. 10 (March 31, 2015: Rs. 10)

50,281

42,175

18,292

50,281

18,292

13

Reserves excluding revaluation reserves as per balance sheet of previous

-

-

-

22,419

2,612

accounting year

14

Earnings/(Loss) per share (of Rs. 10/- each) (not annualised in case of the

interim periods):

1.82

0.84

0.59

(a)

- Basic

(0.27)

2.02

(b)

- Diluted

(0.27)

1.31

0.84

2.02

0.59

Statement of consolidated assets and liabilities

 

( Rs. in Lakhs)

Particulars

As at March 31,2016

As at March 31, 2015

A

Audited

Audited

Equity and liabilities

1

Shareholders' funds

50,281

18,292

(a)

Share capital

(b)

Reserves and surplus

22,419

2,612

Sub-total - Shareholders' funds (a+b)

72,700

20,904

2

Non-current liabilities

(a)

Long-term borrowings

4,340

57,769

(b)

Other long-term liabilities

610

9,320

(c)

Long-term provisions

295

320

Sub-total - Non-current liabilities (a+b+c)

5,245

67,409

3

Current liabilities

(a)

Short-term borrowings

10,396

12,507

(b)

Trade payables - other than acceptances

1,677

3,414

(c)

Other current liabilities

12,851

7,059

(d)

Short-term provisions

1,431

827

Sub-total - Current liabilities (a+b+c+d)

26,355

23,807

TOTAL - EQUITY AND LIABILITIES (1+2+3)

104,300

112,120

B

Assets

1

Non-current assets

(a)

Fixed assets

730

818

(b)

Goodwill on consolidation (refer note 5)

76,772

85,642

(c)

Long-term loans and advances

2,941

2,983

(d)

Other non-current assets

239

752

Sub-total - Non-current assets (a+b+c+d)

80,682

90,195

2

Current assets

(a)

Trade receivables

11,148

10,860

(b)

Cash and cash equivalents

8,600

4,918

(c)

Short-term loans and advances

1,169

869

(d)

Other current assets

2,701

5,278

Sub-total - Current assets (a+b+c+d)

23,618

21,925

TOTAL - ASSETS (1+2)

104,300

112,120

Notes :

1The above results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on May 24, 2016.

2The Financial Results of Subex Limited (Standalone Information):

( Rs. in Lakhs)

Particulars

3 months ended

Preceding 3 months

Corresponding 3

Current year ended

Previous year ended

March 31,

ended December 31,

months ended March 31,

March 31,

March 31,

2016

2015

2015

2016

2015

Audited (refer note

Unaudited

Audited (refer note 11)

Audited

Audited

11)

Net sales/ income from operations

8,286

7,634

9,526

29,624

30,567

Profit/(Loss) from ordinary activities before tax

(20,826)

6,121

271

(12,661)

(2,685)

Profit/(Loss) from ordinary activities after tax

(20,843)

5,952

221

(13,195)

(2,840)

 

3 (a) Pursuant to the approval of the holders of "US$ 180 Million 2% convertible unsecured bonds", [of which US$ 39 Million was outstanding ("FCCBs I")] and "US$ 98.7 Million 5% convertible unsecured bonds", [of which US$ 54.8 Million was outstanding ("FCCBs II")], at their respective meetings held on July 05, 2012 and exchange offers received under the exchange offer memorandum

 

dated June 13, 2012, holders of US$ 38 Million out of FCCBs I and US$ 53.4 Million out of FCCBs II offered their bonds for exchange. Consequently, secured bonds with a face value of US$ 127.721 Million ("FCCBs III") were issued with maturity date of July 07, 2017, having an interest rate of 5.70% p.a. payable semi-annually, an exchange rate for conversion of Rs. 56.0545/US$ and an equity conversion price of Rs. 22.79 per equity share. In accordance with the terms of FCCBs III, principal amount of US$ 36.321 Million was mandatorily converted into equity shares at the aforesaid conversion price on July 07, 2012. Further, pursuant to the approval of the Reserve Bank of India dated April 27, 2012 and requisite approvals of the bond holders, the maturity period of the un-exchanged portion of FCCBs I of US$ 1 Million and FCCBs II of US$ 1.4 Million stands extended to March 09, 2017, with its other terms and conditions remaining unchanged.

 

(b) The Board in its meeting held on May 14, 2015 has approved the reset of conversion price of the FCCBs III, which are convertible into equity shares of the Company, from Rs. 22.79 to Rs. 13.00 per equity share. Subsequently, the reset of the conversion price has been approved by the shareholders in the annual general meeting held on June 19, 2015 and the bondholders in their meeting held on August 5, 2015. The Board in its meeting held on August 26, 2015 has approved August 26, 2015 as the effective date of reset of conversion price of Rs. 13 per share.

 

As a result of the aforesaid reset of conversion price, the said bonds with outstanding face value of US$ 4.55 Million as at March 31, 2016 would potentially be converted into 19,619,075 equity shares at an exchange rate of Rs. 56.0545/US$ with a conversion price of Rs. 13 per equity share. Subsequent to balance sheet date, conversion requests from the bondholders of FCCBs III amounting to US$ 0.45 Million have been received by the Company, which have been approved by the Board of Directors in the Board meeting dated April 28, 2016, and allotted 1,940,348 equity shares at an exchange rate of Rs. 56.0545/US$ with a conversion price of Rs. 13 per equity share.

 

(c) (i) Of the outstanding FCCBs III of US$ 91.40 Million as of July 2012, US$ 86.85 Million have been converted till the quarter and year ended March 31, 2016 as detailed below:

 

Financial year/ period

FCCBs converted

Conversion rate per

Conversion price

No. of equity shares

US$ Million

US$

2012-13

3.25

Rs. 56.0545

Rs. 22.79

7,993,931

2014-15

6.62

Rs. 56.0545

Rs. 22.79

16,282,613

2015-16

76.98

Rs. 56.0545

Rs. 22.79/ Rs. 13.00

319,889,071

Quarter wise details for the financial year 2015-16:

Quarter ended June 30, 2015

6.50

Rs. 56.0545

Rs. 22.79

15,987,461

Quarter ended September 30, 2015

15.10

Rs. 56.0545

Rs. 13.00

65,109,454

Quarter ended December 31, 2015

36.58

Rs. 56.0545

Rs. 13.00

157,728,731

Quarter ended March 31, 2016

18.80

Rs. 56.0545

Rs. 13.00

81,063,425

(c)(ii) The face value of FCCBs outstanding as on March 31, 2016 is as follows:

Particulars

US$ Million

Rs. in Lakhs

FCCBs I

1.00

663

FCCBs II

1.40

928

FCCBs III

4.55

3,015

Total

6.95

4,606

 

(d) The FCCB bond holders in their respective meetings have approved the deferral of aggregate interest of US$ 0.92 Million ( Rs. 610.48 Lakhs) in respect of outstanding FCCBs III of USD 4.55 Million for the period July 6, 2012 to January 5, 2016 till redemption date of the bonds, being July 07, 2017. Accordingly, interest on FCCBs III included under finance costs in the above results to the extent of above deferrals is due for payment on July 07, 2017.

 

4Exceptional items:

( Rs. in Lakhs)

Particulars

3 months ended

Preceding 3 months

Corresponding 3

Current year ended

Previous year ended

March 31,

ended December 31,

months ended March 31,

March 31,

March 31,

2016

2015

2015

2016

2015

Audited (refer note

Unaudited

Audited (refer note 11)

Audited

Audited

11)

i. FCCBs

Reversal of interest accrued but not due pertaining to converted FCCBs

2,774

4,744

-

10,416

-

(refer note 4[i][a])

Foreign exchange gain on FCCBs conversion (net) (refer note 4[i][b])

759

876

-

2,159

-

Others

3,533

5,620

-

12,575

-

ii. Reversal of interest accrued but not due pertaining to Term Loans (refer note

1,970

-

-

1,970

-

4[ii])

iii. Loss on Impairment of goodwill (refer note 4[iii])

(8,870)

-

-

(8,870)

-

Total

(3,367)

5,620

-

5,675

-

 

(i)(a) Interest accrued but not due pertaining to FCCBs III converted during the current year has been written back as the same is considered no longer payable due to the conversion of FCCBs III into equity shares of the Company.

 

(i)(b) FCCBs III have been converted into equity shares at an exchange rate of Rs. 56.0545/US$ as per the FCCBs trust deed, as against the closing rate on the date of conversion (in the range of Rs. 60 - Rs. 66) resulting in foreign exchange gain on conversion. Further, the Foreign Currency Monetary Item Translation Difference Account ('FCMITD') balance pertaining to FCCBs III converted into equity shares, has been charged off in the statement of profit and loss for the quarter and year ended March 31, 2016 on the date of conversion.

 

(ii) During the quarter ended March 31, 2016, certain lenders of term loans have waived interest liability outstanding till March 26, 2016 and interest liability accruing thereafter upto August 22, 2016, pursuant to the interest waiver agreement dated March 26, 2016 subject to the fulfilment of certain conditions. Consequent to fulfilment of such conditions, the accrued interest of US$ 2.9 Million ( Rs. 1,970 Lakhs) on outstanding term loan balance of US$ 12 Million ( Rs. 7,951 Lakhs) as at March 31, 2016 has been written back, as the same is no longer payable. Further, pursuant to the aforesaid agreeement, the interest rate has been revised from the existing interest rate of 10.5% per annum to 5% per annum, effective August 22, 2016.

 

(iii) As at March 31, 2016, the Company has assessed the carrying value of goodwill relating to its investment in the subsidiary viz. Subex Americas Inc., amounting to Rs. 18,606 Lakhs. Based on future operational plan, projected cash flows and valuation carried out by an external valuer, the Company has made an impairment provision of Rs. 8,870 Lakhs towards the carrying value of goodwill relating to its investment in the said subsidiary.

 

5 As at March 31, 2016, the Company has assessed the carrying value of goodwill relating to its investment in the subsidiary viz. Subex (UK) Limited, amounting to Rs. 67,036 Lakhs. Based on the future operational plan, projected cash flows and the valuation carried out by an external valuer, the management is of the view that, the aforesaid carrying value of goodwill as at March 31, 2016 relating to its investment in the said subsidiary is appropriate.

 

6 Cost of hardware, software and support charges for the quarter ended March 31, 2016, December 31, 2015 and March 31, 2015 is net of reversal of provision no longer required, amounting to Rs. 213 Lakhs, Rs. Nil and Rs. Nil, respectively and that for the year ended March 31, 2016 and March 31, 2015 amounting to Rs. 386 Lakhs and Rs. Nil, respectively.

 

7 Employee benefits expense and sub-contract charges for the quarters ended March 31, 2016, December 31, 2015 and March 31, 2015 are net of reversal of provision no longer required, in respect of employee incentives, amounting to Rs. 192 Lakhs, Rs. 420 Lakhs, and Rs. 904 Lakhs, respectively and that for the year ended March 31, 2016 and ended March 31, 2015 amounting to Rs. 1,065 Lakhs and Rs. 1,191 Lakhs, respectively.

 

8 Other expenditure for the quarter ended March 31, 2016, December 31, 2015 and March 31, 2015 is net of reversal of provision no longer required, in respect of commission on sales, amounting to Rs. 68 Lakhs, Rs. 146 Lakhs and Rs. Nil, respectively and that for the year ended March 31, 2016 and March 31, 2015 amounting to Rs. 214 Lakhs, and Rs. Nil, respectively.

9 Pursuant to the approval of the Board of Directors, the Group has discontinued the operations of two of its subsidiaries with effect from April 01, 2013. The details of unaudited/audited results of the discontinued businesses consolidated in the above results are as follows:

Particulars

3 months ended

Preceding 3 months

Corresponding 3

Current year ended

Previous year ended

March 31,

ended December 31,

months ended March 31,

March 31,

March 31,

2016

2015

2015

2016

2015

Audited (refer note

Unaudited

Audited (refer note 11)

Audited

Audited

11)

Total income

-

-

-

-

-

(Loss) /Profit before tax

(2.10)

(0.91)

(393.20)

(5.23)

(474.18)

(Loss) /Profit after tax

(2.12)

(0.93)

(398.54)

(2.33)

(479.80)

 

10 The Group has only single business segment with respect to software products and related services and hence has not made any additional segment disclosures.

 

11 The figures of last quarter of current and previous years are the balancing figures between the audited figures in respect of the full financial years and the published unaudited year to date figures for nine months of respective years.

 

12 The figures for the previous period/ year up to March 31, 2015 were audited/ reviewed by a firm of Chartered Accountants other than S.R. Batliboi & Associates LLP. Previous period/year figures have been regrouped/ reclassified, wherever necessary to confirm to current period's/ year's classification.

 

13 Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Company has opted to publish the consolidated financial results. The standalone financial results, however, are being made available to the Stock Exchanges where the securities of the Company are listed and are also being posted on the Company's website www.subex.com.

 

 

 

Bengaluru

Surjeet Singh

Date: May 24, 2016

Managing Director & CEO

For further details on the results, please visit our website: www.subex.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUVSKRNKAVURR
Date   Source Headline
9th Aug 202210:35 amRNSOutcome of the Board Meeting held on August 8,2022
30th Jun 20223:42 pmRNSProposed termination of GDRs & De-listing
1st Jun 202211:52 amRNSOutcome of Board Meeting dated May 30, 2022
1st Feb 202211:11 amRNSOutcome of Board Meeting held on Jan 31, 2022
29th Oct 20218:37 amRNSOutcome of Board Meeting held on October 28, 2021
10th Aug 202111:41 amRNSOutcome of the Board Meeting on August 09, 2021
15th Jun 202111:56 amRNSNotice of Twenty Seventh Annual General Meeting
18th May 202111:20 amRNSOutcome of the Board Meeting held on May 17, 2021
2nd Feb 202112:38 pmRNSOutcome of the Board Meeting February 01,2021
10th Nov 202011:32 amRNSOutcome of the Board Meeting November 09,2020
1st Sep 202012:01 pmRNSNotice of the Twenty Sixth Annual General Meeting
11th Aug 20202:34 pmRNSOutcome of Board Meeting on August 10, 2020
12th May 20207:31 amRNSSubex Limited-Outcome of Board Meeting 11 May 2020
12th Feb 20207:00 amRNSOutcome of the Board Meeting of Subex Limited
11th Nov 201910:17 amRNSResults for quarter & half year ended Sep 30, 2019
13th Aug 201911:02 amRNSOutcome of the Board Meeting - August 12, 2019
10th Jun 201911:55 amRNSNotice of the Twenty Fifth Annual General Meeting
14th May 20199:51 amRNSSubex Limited Outcome -Board Meeting -May 13, 2019
30th Jan 20197:00 amRNSOutcome of the Board Meeting held on Jan 29, 2019
2nd Nov 20187:08 amRNSOutcome of the Board Meeting- October 31, 2018
1st Aug 20187:00 amRNS1st Quarter Results
12th Jul 20187:26 amRNSThe Twenty Fourth AGM of Subex Limited
27th Jun 20187:38 amRNSSubex Limited-Outcome -Board Meeting June 26,2018
4th May 20183:00 pmRNSFinal Results
22nd Mar 201811:29 amRNSAppointment of MD & CEO of Subex Ltd
30th Jan 20189:50 amRNSFinancial Results - 3rd Quarter
13th Nov 201710:01 amRNSOutcome of Board Meeting held on November 10 2017
2nd Nov 201711:54 amRNSRestructuring of the Business wef Nov 1, 2017
5th Oct 20177:00 amRNSOutcome of Board Meeting held on October 4, 2017
22nd Aug 201711:47 amRNSOutcome of Board Meeting held on August 21, 2017
31st Jul 201711:38 amRNS1st Quarter Results
10th Jul 201711:40 amRNSRedemption of FCCB III
4th Jul 201711:05 amRNSNotice of AGM
5th Jun 201711:25 amRNSOutcome of the Board Meeting held on June 05, 2017
5th Jun 201711:15 amRNSOutcome of the Board Meeting held on June 05, 2017
26th May 20177:00 amRNSFinal Results
24th Mar 201711:41 amRNSOutcome of the Board Meeting held on March 24 2017
7th Mar 20178:26 amRNSIntimation on Redemption of FCCBs
3rd Feb 201710:46 amRNSSubex Limited 3rd Quarter Results
7th Dec 20167:50 amRNSOutcome of Board Meeting held on December 06 2016
14th Sep 20167:47 amRNS1st Quarter Results
22nd Aug 201611:14 amRNSNotice of AGM
10th Aug 201610:43 amRNSOutcome of the Board Meeting- August 9, 2016
25th May 201610:51 amRNSSubex Limited-Outcome of Board Meeting
11th Feb 201612:18 pmRNS3rd Quarter Results
3rd Nov 20152:44 pmRNSResult of Meeting
27th Aug 20158:45 amRNSSubex Limited (The Company)-Update
13th Aug 20152:00 pmRNS1st Quarter Results
3rd Jul 201511:55 amRNSNotice of the Outcome of Bondholders meeting
27th May 201512:44 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.